Strategic Plan

March 24, 2016

Deep brain stimulation program marks milestones

Vanderbilt Clinical Neurosciences is marking two milestones — the 20th anniversary of its deep brain stimulation (DBS) program and its 1,000th DBS procedure.

By Tom Wilemon
March 22, 2016

New treatment for Crohn’s disease

A new biological therapy, ustekinumab, improves markers of disease activity in patients with severe Crohn’s disease.

By Leigh MacMillan
March 18, 2016

Monroe Carell Jr. Children’s Hospital at Vanderbilt and Ryan Seacrest Foundation Open Seacrest Studios, a New Multimedia Broadcast Studio

By Christina Echegaray
alarm clock
March 17, 2016

Study suggests cancer’s ‘clock’ can be rewound

Researchers at Vanderbilt University Medical Center have “turned back the clock” in a mouse model of metaplasia — precancerous stomach lesions — raising hopes that gastric cancer, a worldwide scourge that’s rising in the United States, can be prevented.

By Bill Snyder
March 17, 2016

Life-changing impact of cornea transplantation celebrated

Since 1961, the Eye Bank Association of America has provided donors for more than 1.5 million corneal transplants nationwide. And for nearly 25 years, the group has celebrated corneal transplant recipients, promoted awareness of the need to donate and recognized donors and families during National Eye Donor Month in March.

By Jessica Pasley
March 17, 2016

Study explores carb-loading’s effect on heart

Drinking a high carbohydrate shake can have an acute and detrimental effect on heart function, a study published in the Journal of the American College of Cardiology (JACC) has found.

By Kathy Whitney
March 10, 2016

FDA approves Vanderbilt-designed Indego exoskeleton for clinical and personal use

The U.S. Food and Drug Administration has given clearance to market and sell the powered lower-limb exoskeleton created by a team of Vanderbilt engineers and commercialized by the Parker Hannifin Corporation for both clinical and personal use in the United States.
By VUMC News and Communications
March 7, 2016

Vanderbilt researchers identify potential antibody treatment for H7 avian flu

Researchers at Vanderbilt University Medical Center have isolated human antibodies against a type of bird flu that has killed more than 200 people in China since 2012 and which may pose a worldwide pandemic threat.
By Bill Snyder
March 3, 2016

First VICC cancer patient treated with new immunotherapy

For the first time, Vanderbilt-Ingram Cancer Center (VICC) investigators have used a cancer patient’s own re-engineered immune cells to treat a form of blood cancer by stimulating the immune system.
By VUMC News and Communications
March 3, 2016

Study seeks to ease pediatric HIV infection rates in Africa

Mother-to-child transmission of the human immunodeficiency virus (HIV), which causes AIDS, is still a major problem in resource-limited, rural areas of the world where health care providers are scarce.
By Bill Snyder
February 18, 2016

Compassion key to VUMC’s strategic mission: Balser

“Service through compassion” was the theme of the Winter 2016 Clinical Enterprise Leadership Assembly at Vanderbilt University Medical Center (VUMC).
By Paul Govern
February 18, 2016

Study explores less invasive way to monitor colorectal cancer

Investigators at Vanderbilt University Medical Center have published research regarding an important feature of colorectal cancer (CRC) that could eventually lead to the development of non-invasive means of monitoring cancer progression. After lung cancer, CRC is the second-most lethal cancer in the United States.
By VUMC News and Communications
February 18, 2016

Liver transplant program celebrates 25 years of care

Twenty-five years ago, Julie Damon’s family was preparing to say their goodbyes. Comatose and on life support at Vanderbilt University Medical Center (VUMC) with liver failure, the options for the 45-year-old wife and mother of two were slipping away.
By Jessica Pasley
1 … 4 5 6 7 8 … 17